Subscribe to Newsletter

Advanced Medicine

Discovery & Development Drug Discovery

Characterizing RNA-Based Medicines

| Matthew Lauber, Andrew Argo, Elizabeth Foley | 5 min read

How precision analytics is driving the future of pharmaceuticals, from small molecules to CRISPR gene editing.

Manufacture Advanced Medicine

AI Approach to Transdermal GLP-1s

| 3 min read

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

Business & Regulation Trends & Forecasts

Our Videos: The Greatest Hits

| 1 min read

From gene therapy to novel excipients to trends in leadership and more. Check out some of our most popular videos.

Manufacture Advanced Medicine

Integrating Technology and Robotics in CGT Manufacturing

| 7 min read

How the right partnerships are helping streamline CGT manufacturing through robotics and digital tools.

Business & Regulation Profession

Maintaining Momentum

| 4 min read

Being part of the cell and gene therapy field is an incredible privilege, according to Frank Mathias, CEO, Oxford Biomedica.

Manufacture Advanced Medicine

Digital Twins in CAR-T Manufacturing

| Marc-Olivier Baradez | 4 min read

Here’s why the Cell and Gene Therapy Catapult is excited about the potential of digital twin technology.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3

| Stephanie Vine | 6 min read

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Discovery & Development Advanced Medicine

Complex DNA; No Compromises

| Daniel Lin-Arlow | 4 min read

How can you ensure your gene therapy research won’t be slowed down by synthesis problems?

Discovery & Development Advanced Medicine

Incredible Advancements

| 5 min read

Sitting Down With… Matthew Durdy, Chief Executive, Cell and Gene Therapy Catapult.

Business & Regulation Trends & Forecasts

The Arrival and Maturity of Personalized Medicine and AI

| 2 min read

What lies ahead for the future of pharma? Dennis van Rooji gives his view.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register